...told Business Line. “We are currently reviewing the decision and will look at the various options available to us,” a Novartis spokesperson said, without indicating if the company would appeal the judgment. Swiss drug-maker Novartis’ product patent on Glivec...

...the world has been on the rise thanks to increasing demand, including the U.S. requirement of some 600 million doses. Citing Novartis AG as an example, Kao said the Switzerland-based drug company sold the vaccine at between US$8 and US$10 per dose to early...

...Sindhoori Capital Investment, Balaji Distilleries, Bang Overseas, Hinduja Foundries, IOL Netcom, Nagarjuna Fertiliser & Chem, Novartis India, Pennisula Land, Reliance Industrial Infrastructure, STC, and Vishal Retail, among others. Among the new inclusions...

...the AcademyHealth meeting in Chicago. Forbes reports: "That research, from the University of Maryland School of Pharmacy and funded by Novartis Pharmaceuticals, found "small but statistically significant" improvements in health status, based on daily activity...

...party to take a minority stake in the company and the likes of Pfizer, Roche, Lundbeck, Bristol-Myers Squibb and,most recently, Novartis, were linked with Elan. J&J has won the day, however, and Husseini Manji, head of neuroscience, said that “we expect to...

...clot. Lucentis is currently approved for the treatment of neovascular age-related macular degeneration and is co-marketed with Novartis. The BRAVO trial involved six-monthly injections of Lucentis compared to monthly sham injections and two doses of the drug...

...rest will come from Baxter, using a rapid cell-culture method. That same pioneering method has been developed by German firm Novartis, which yesterday claimed that it had produced the first swine flu vaccine. So far it has orders from 35 governments for its...

...cap pharma groups, several big pharma groups and financial firms running an eye over the company. Rumours this weekend that Novartis was poised to make a move indicates that there may have been serious competition driving the price up. Back in June, market...

...its production methods for generic drugs sold in the UK, including a version of the anti-depressant Prozac made by Swiss giant Novartis, failed the minimum standards set by the European Union. Other drugs involved in the recall included hypertension pills,...

...and lab experiments suggest the drugs tolcapone or Tasmar made by Valeant Pharmaceuticals , and entacapone or Comtan made by Novartis AG have the potential to treat multiple-drug-resistant and extensively drug-resistant strains of TB. Computer...